# Comp En De Mn Cemig (CIG) fundamentals

Data as of 2026-11-04. NYSE, United States. Sector: Utilities / Electric Utilities. Price $1.79, market value $5.1 billion.

## Valuation
- **P/E (trailing): 5.8×** (5-yr avg 1.1×, 3-yr avg 1.1×). Comp En De Mn Cemig trades at 5.8× trailing earnings, well above its own five-year average of 1.1×: investors are paying up relative to the company's past. The Utilities median in the September 2026 study was 21.2×. Forward P/E is 59.7×, higher than trailing, so analysts expect earnings to fall.
- **Price / sales: 0.6×**. Each dollar of revenue is priced at 0.6×, a low multiple typical of thin-margin businesses or out-of-favour stocks.
- **Price / book: 0.9×**. The shares trade below book value, which can signal a bargain or a balance sheet the market doubts.
- **EV / EBITDA: 5.0×**. Enterprise value is 5.0× operating earnings before depreciation, the multiple that ignores how the company is financed; below 8× is inexpensive for most sectors.
- **Free-cash-flow yield: 10.7%** (5-yr avg 55.7%). Free cash flow equals 10.7% of the market value, below its five-year average of 55.7%, so the shares are pricier on cash than usual. Above 5% is generally attractive.
- **Earnings yield: 17.3%**. The inverse of the P/E: 17.3% of the price is earned each year.

## Profitability
- **Gross margin: 15.3%**. Comp En De Mn Cemig keeps 15.3% of revenue after the direct cost of what it sells, a thin margin typical of retail, distribution and commodity businesses.
- **Operating margin: 15.2%**. 15.2% of revenue is left after running the business, a healthy level in most sectors.
- **Net margin: 11.5%**. 11.5% of each dollar of sales reaches the bottom line.
- **Return on equity: 17.1%**. 17.1% on shareholders' equity is solid.
- **Return on invested capital: 13.4%**. Return on all capital, debt included, is 13.4%.
- **Return on assets: 6.9%**. Each dollar of assets produces 6.9% of profit.

## Growth
- **Revenue growth (1 yr): 7.4%** (3-yr 7.4%/yr, 5-yr 11.1%/yr). Revenue grew 7.4% over the last year, against 11.1% a year compounded over five years: growth is slowing.
- **Free-cash-flow growth (3 yr): -22.2%/yr**. Free cash flow has compounded at -22.2% a year over three years.

## Financial health
- **Debt to equity: 0.70**. Debt is 0.70 times equity, moderate leverage.
- **Net debt / EBITDA: 1.8×**. It would take 1.8 years of operating earnings to repay net borrowings, within the comfortable range.
- **Interest coverage: 2.6×**. Operating profit covers interest 2.6×, thin but manageable.
- **Current ratio: 1.00** (quick 1.00). Current assets cover the next year's liabilities 1.00 times.
- **Altman Z-score: 1.63**. A Z-score of 1.63 is in the distress zone, a signal to examine the balance sheet closely.
- **Piotroski F-score: 3/9**. 3 of 9 checks pass: weak or deteriorating financials.

## Dividends
- **Dividend yield: 8.17%** ($0.15 per share, trailing). Comp En De Mn Cemig yields 8.17%, high enough to check carefully: yields this high often precede a cut.
- **Dividend growth (5 yr): 20.6%/yr** (1-yr -7.0%). The dividend has compounded at 20.6% a year over five years, doubling roughly every 3 years at that pace.

## Analyst view
- **Analyst consensus: underperform** (3 analysts). 3 analysts cover Comp En De Mn Cemig; the consensus is underperform, with an average price target of $1.99 (+11% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): -7.5%** (YTD -3.3%, 3-mo -16.5%). The shares are down 7.5% over twelve months including dividends.
- **From 52-week high: -35.1%** (1.1% above the low). Trading 35% below its 52-week high, deep in a drawdown.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 28**. An RSI of 28 is oversold; bounces are common, but oversold can stay oversold in a real decline.
- **Beta (1 yr): 0.66** (volatility 37%). Beta of 0.66 against the S&P 500: the shares move much less than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=CIG · Page: https://foliofundamentals.com/stocks/cig

Not investment advice.